Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP Immunopathogenesis.
Birtas Atesoglu E, Tarkun P, Demirsoy ET, Geduk A, Mehtap O, Batman A, Kaya F, Cekmen MB, Gulbas Z, Hacıhanefioglu A. Birtas Atesoglu E, et al. Among authors: geduk a. Clin Appl Thromb Hemost. 2016 Apr;22(3):248-51. doi: 10.1177/1076029614562952. Epub 2014 Dec 14. Clin Appl Thromb Hemost. 2016. PMID: 25510412 Free article.
Dasatinib-induced immune mediated-thrombotic thrombocytopenic purpura.
Demirsoy ET, Mehtap O, Atesoglu EB, Tarkun P, Eren N, Gedük A, Hacihanefioglu A. Demirsoy ET, et al. Among authors: geduk a. Transfus Apher Sci. 2018 Apr;57(2):222-224. doi: 10.1016/j.transci.2018.02.003. Epub 2018 Feb 9. Transfus Apher Sci. 2018. PMID: 29475747
Excellent Interim Treatment Response with Polatuzumab Vedotin.
Mehtap Ö, Dağlıöz Görür G, Ünal S, Gedük A. Mehtap Ö, et al. Among authors: geduk a. Turk J Haematol. 2020 Nov 19;37(4):284-285. doi: 10.4274/tjh.galenos.2020.2020.0042. Epub 2020 Jul 1. Turk J Haematol. 2020. PMID: 32608220 Free PMC article. No abstract available.
Serum calprotectin (S100A8/A9) levels as a new potential biomarker of treatment response in Hodgkin lymphoma.
Şumnu Ş, Mehtap Ö, Mersin S, Toptaş T, Görür G, Gedük A, Ünal S, Polat MG, Aygün K, Yenihayat EM, Albayrak H, Uluköylü Mengüç M, Tarkun P, Hacıhanifioğlu A. Şumnu Ş, et al. Among authors: geduk a. Int J Lab Hematol. 2021 Aug;43(4):638-644. doi: 10.1111/ijlh.13559. Epub 2021 Apr 27. Int J Lab Hematol. 2021. PMID: 33904653 Clinical Trial.
29 results